CA2719940A1 - Methods for treating acute myocardial infarction - Google Patents

Methods for treating acute myocardial infarction Download PDF

Info

Publication number
CA2719940A1
CA2719940A1 CA2719940A CA2719940A CA2719940A1 CA 2719940 A1 CA2719940 A1 CA 2719940A1 CA 2719940 A CA2719940 A CA 2719940A CA 2719940 A CA2719940 A CA 2719940A CA 2719940 A1 CA2719940 A1 CA 2719940A1
Authority
CA
Canada
Prior art keywords
gly
asp
seq
glu
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2719940A
Other languages
English (en)
French (fr)
Inventor
Randolph C. Steer
Michael R. Sheller
John D. Wagstaff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
Orthologic Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orthologic Corp filed Critical Orthologic Corp
Publication of CA2719940A1 publication Critical patent/CA2719940A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2719940A 2008-03-26 2009-03-26 Methods for treating acute myocardial infarction Abandoned CA2719940A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US7083708P 2008-03-26 2008-03-26
US61/070,837 2008-03-26
US13795308P 2008-08-05 2008-08-05
US61/137,953 2008-08-05
PCT/US2009/001954 WO2009142679A2 (en) 2008-03-26 2009-03-26 Methods for treating acute myocardial infarction

Publications (1)

Publication Number Publication Date
CA2719940A1 true CA2719940A1 (en) 2009-11-26

Family

ID=41170019

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2719940A Abandoned CA2719940A1 (en) 2008-03-26 2009-03-26 Methods for treating acute myocardial infarction

Country Status (5)

Country Link
US (1) US20110105400A1 (enExample)
EP (1) EP2268304A2 (enExample)
JP (1) JP2011515471A (enExample)
CA (1) CA2719940A1 (enExample)
WO (1) WO2009142679A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009229395A1 (en) 2008-03-26 2009-10-01 The Board Of Regents, The University Of Texas System Method of treating degenerative diseases
US20160199406A1 (en) * 2013-08-19 2016-07-14 Klaus Michael SCHMIDT Non-anesthetic protective gases in combination with liquid anesthetic agents for organ protection
US10220078B2 (en) 2014-06-11 2019-03-05 The Board Of Regents Of The University Of Texas System Methods of using thrombin derivatives to treat medulloblastoma

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352664A (en) * 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
US6630572B1 (en) * 1986-10-31 2003-10-07 The Board Of Regents, University Of Texas Syatems Thrombin derived polypeptides: compositions and methods for use
US5244460A (en) * 1991-11-27 1993-09-14 The United States Of America As Represented By The Department Of Health And Human Services Method to foster myocardial blood vessel growth and improve blood flow to the heart
KR100459984B1 (ko) * 1995-06-07 2005-06-20 아피맥스 테크놀로지스, 엔.브이. 에리트로포이에틴수용체(epo-r)에결합하는화합물및펩티드
WO1997015598A1 (fr) * 1995-10-24 1997-05-01 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Nouveau peptide
US5912229A (en) * 1996-03-01 1999-06-15 Novo Nordisk Als Use of a pharmaceutical composition comprising an appetite-suppressing peptide
US6197751B1 (en) * 1997-11-10 2001-03-06 The United States Of America As Represented By The Department Of Health And Human Services Thymosin α1 promotes tissue repair, angiogenesis and cell migration
US6033436A (en) * 1998-02-17 2000-03-07 Md3, Inc. Expandable stent
US20030130209A1 (en) * 1999-12-22 2003-07-10 Cheresh David A. Method of treatment of myocardial infarction
US20040214836A1 (en) * 1998-05-29 2004-10-28 Cheresh David A. Method of treatment of myocardial infarction
JP2002527401A (ja) * 1998-10-13 2002-08-27 カイロン コーポレイション Ｆｇｆの脈管形成的に有効な単位用量および投与方法
US6363938B2 (en) * 1998-12-22 2002-04-02 Angiotrax, Inc. Methods and apparatus for perfusing tissue and/or stimulating revascularization and tissue growth
US20020063763A1 (en) * 2000-11-29 2002-05-30 Mantell David Allen Apparatus and method for removing air bubbles from an ink jet printhead
TWI257307B (en) * 2000-07-12 2006-07-01 Orthologic Corp Pharmaceutical composition for cardiac tissue repair
EP1301196B1 (en) * 2000-07-19 2003-11-26 The Board of Regents, The University of Texas System Stimulation of bone growth with thrombin peptide derivatives
CN1458974A (zh) * 2000-07-20 2003-11-26 德克萨斯系统大学董事会 用非蛋白质水解激活的凝血酶受体的激动剂刺激软骨生长
JP4192093B2 (ja) * 2001-07-27 2008-12-03 ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム 慢性皮膚潰瘍の治癒を促進する方法
EP1467749B1 (en) * 2002-01-16 2011-04-06 Capstone Therapeutics Corp. Thrombin derived peptides for promoting cardiac tissue repair
WO2004014937A2 (en) * 2002-07-02 2004-02-19 The Board Of Regents, The University Of Texas System Thrombin peptide derivatives
CA2491135A1 (en) * 2002-07-02 2004-01-15 The Board Of Regents, The University Of Texas System Thrombin peptide derivative dimers
ITRM20030178A1 (it) * 2003-04-17 2004-10-18 Sigma Tau Ind Farmaceuti Uso della l-carnitina per il trattamento di patologie cardiovascolari.
PL1559431T3 (pl) * 2003-12-31 2007-10-31 Orthologic Corp Kompozycja farmaceutyczna dla pochodnych peptydu trombiny
AU2006259408A1 (en) * 2005-06-17 2006-12-28 Genentech, Inc. Use of VEGF for wound healing
CN101563102B (zh) * 2006-09-22 2014-12-17 德克萨斯系统大学董事会 治疗内皮功能障碍的方法
EP2155234A1 (en) * 2007-04-10 2010-02-24 The Board of Regents,The University of Texas System Combination therapy for chronic dermal ulcers
EP2155236A1 (en) * 2007-04-10 2010-02-24 The Board of Regents,The University of Texas System Combination therapy for cardiac revascularization and cardiac repair
AU2009229399A1 (en) * 2008-03-26 2009-10-01 Orthologic Corp. Thrombin derived peptides for smooth muscle relaxation

Also Published As

Publication number Publication date
AU2009249629A1 (en) 2009-11-26
WO2009142679A3 (en) 2010-01-14
JP2011515471A (ja) 2011-05-19
EP2268304A2 (en) 2011-01-05
WO2009142679A2 (en) 2009-11-26
US20110105400A1 (en) 2011-05-05

Similar Documents

Publication Publication Date Title
JP6229038B2 (ja) 修飾された血管作動性腸管ペプチド
US8541545B2 (en) Stabilized melanocortin ligands
WO2010013012A4 (en) Hypothermia inducing polypeptides and uses thereof
EP2064234A2 (en) Bioactive peptides and method of using same
KR20130093693A (ko) 포도당 의존적인 인슐린 분비 자극성 폴리펩타이드의 절단형 유사체
JP5002603B2 (ja) 新規なペプチド及びこれの用途
KR20110043688A (ko) 포도당 의존적인 인슐린 분비 자극성 폴리펩타이드 유사체
JP2005053930A5 (enExample)
JP2010504336A5 (enExample)
WO2018069442A1 (en) Peptide dual agonists of gipr and glp2r
JP2014508765A (ja) 副甲状腺ホルモン類似体、組成物およびその使用
JP2006514822A5 (enExample)
CA2719940A1 (en) Methods for treating acute myocardial infarction
CN110831957B (zh) Apoc-ii模拟肽
US20110195900A1 (en) Peptidic pth receptor agonists
AU2010216383B2 (en) Analogues of neuropeptide Y having at least one synthetic amino acid substitution
JP2011515471A5 (enExample)
KR102520348B1 (ko) 페길화 생활성 펩타이드 및 그의 용도
CN108976291A (zh) 一种改善糖尿病和老年性痴呆的十六肽
JP6113144B2 (ja) 成長ホルモン放出因子（ｇｒｆ）類似体およびその使用
WO1992014834A1 (en) Insulin-like growth factor binding protein
CA2722618A1 (en) Method of treating degenerative diseases
JP2003501109A5 (enExample)
KR102166543B1 (ko) 켈로이드 억제용 조성물 및 그 억제 방법
JP2013529600A5 (enExample)

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140108

FZDE Discontinued

Effective date: 20160329